Clinical Trial

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
Recently, few studies have attempted to test the regenerative effects of human insulin application by microneedling on atrophic scars versus other topical preparations. However, the scars were limited etiologically to acne scars. In addition, a lack of inclusion of a control group instead of comparing topical preparations with insulin was also a limitation to these studies. A control group consisting of microneedling alone would have served as a better comparison in order to determine whether the effects of microneedling are augmented by topical protein-rich preparations.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06021275
Lead Sponsor Alexandria University
Conditions Scars, Insulin
Enrollment 40 participants
Start Date 2023-10-01
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-30